Shattuck Labs

US · STTK #3662 by market cap Listed 2020

5.44 -0.22 -3.80%

Live - 5344 symbols - heartbeat 42s ago · 2026-10-08 09:58

Pre-market 5.65 -0.09%

After-hours 5.66 0.00%

Overnight 5.57 -1.50%

Market cap: 545.98M
P/E (TTM): -12.36
P/B: 2.59
EPS: -0.70
Div yield: 0.00%
52W pos: 56%

Reader sentiment Are you bullish or bearish on STTK?

Anonymous reader poll. Unscientific, not investment advice.

About Shattuck Labs

Shattuck Labs, Inc. is a clinical-stage biotechnology company, which engages in the research and development of potential treatments for inflammatory and immune-mediated diseases. It focuses on developing a potential first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company was founded by Josiah C. Hornblower and Taylor Schreiber in 2016 and is headquartered in Austin, TX.

Founded: 2016
CEO: Dr. Taylor H. Schreiber, M.D.,PhD
Employees: 40
Headquarters: Austin, Texas, United States of America
Fiscal year end: 12-31
Website: shattucklabs.com

Company profile

Exchange: US
Symbol: STTK
Market-cap rank: #3662
Listing date: 2020-10-09
Market cap: 545.98M
Float cap: 368.61M
Shares out: 100.36M
Float shares: 67.76M

Sectors & themes

Biotechnology

Browse all sectors & themes

Quote time 2026-10-08 09:58:42 · For reference only, not investment advice and not tailored to your situation.